PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if it is feasible to conduct a multi-center
randomized trial to determine whether a blood thinner, low-molecular-weight-heparin (LMWH),
is effective at preventing blood clots, thromboembolism (VTE), in postpartum women at risk.